Skip Navigation

European Heart Journal 1999 20(8):604-611; doi:10.1053/euhj.1998.1231
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Burton, P.B.J.
Right arrow Articles by Barton, P.J.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burton, P.B.J.
Right arrow Articles by Barton, P.J.R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development

P.B.J. Burton, M.H. Yacoub and P.J.R. Bartonf1

Cardiothoracic Surgery, Imperial College of School of Medicine, National Heart and Lung Institute, London, U.K.

revised July 3, 1998; accepted July 12, 1998

Abstract

Aims

Terminal differentiation of cardiac myocyte is associated with their permanent withdrawal from the cell cycle. In adult end-stage heart failure, significant numbers of myocytes express proliferating cell nuclear antigen yet fail to progress to cell division. Cyclin dependent kinase inhibitors are powerful inhibitors of the cell cycle and may play a direct role both in myocyte development and in preventing cell division in the adult.

Methods and Results

The expression of the CIP/KIP cyclin dependent kinase inhibitors p21, p27, p57 and the retinoblastoma protein was examined in acute (seen in brain dead transplant donors) and end-stage heart failure by Western blot analysis and compared to that seen in human and rat cardiac development. The expression of p21 showed a gradual increase during development in both rat and man, becoming maximal in adulthood. p27 levels showed an initial rise with subsequent continual expression throughout life. p57 expression was detectable at only early stages in rat but persisted throughout life in man. In both acute and end-stage heart failure the levels of p21, p27 and p57 reverted to a pattern similar to that observed in human fetal heart: p21 and p27 declined while p57 expression was significantly increased. In contrast, retinoblast protein levels declined during human heart development but were unaltered in heart failure.

Conclusions

The expression of p21, but not p27 or p57, is consistent with a role in the gradual withdrawal of cardiac myocytes from cell cycle during development. In adult heart failure cyclin dependent kinase inhibitor expression reverts to the fetal pattern but is insufficient to initiate cell cycle activation.

Key Words: Cyclin dependent kinase inhibitors, heart failure, human, cardiac development

f1 Correspondence: Paul J. R. Barton, Cardiothoracic Surgery, Imperial College School of Medicine, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, U.K.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
M. Movassagh and A. Philpott
Cardiac differentiation in Xenopus requires the cyclin-dependent kinase inhibitor, p27Xic1
Cardiovasc Res, August 1, 2008; 79(3): 436 - 447.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
P. Ahuja, P. Sdek, and W. R. MacLellan
Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration
Physiol Rev, April 1, 2007; 87(2): 521 - 544.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z.-P. Liu and E. N. Olson
Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase
PNAS, February 19, 2002; 99(4): 2043 - 2048.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
V.J Owen, P.B.J Burton, A.J Mullen, E.J Birks, P Barton, and M.H Yacoub
Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure
Eur. Heart J., June 2, 2001; 22(12): 1015 - 1020.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
H. N. Sabbah
Apoptotic cell death in heart failure
Cardiovasc Res, February 1, 2000; 45(3): 704 - 712.
[Full Text] [PDF]

Home page
 CirculationHome page
V. J. Owen, P. B. J. Burton, M. C. Michel, O. Zolk, M. Bohm, J. R. Pepper, P. J. R. Barton, M. H. Yacoub, and S. E. Harding
Myocardial Dysfunction in Donor Hearts : A Possible Etiology
Circulation, May 18, 1999; 99(19): 2565 - 2570.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.